...
首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
【24h】

Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.

机译:补充因子H缺乏症和移植后肾小球性肾炎,伴有孤立的C3沉积物。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the first cases of atypical hemolytic and uremic syndrome associated with complement factor H (CFH) deficiency in native kidneys and glomerulonephritis with isolated C3 deposits after kidney transplantation. Two boys developed atypical hemolytic and uremic syndrome at 16 and 11 months of age, associated with low C3 and CFH levels. Both rapidly progressed to end-stage renal failure and received a kidney transplant. Patient 1 had combined CFH and complement factor I (CFI) heterozygous mutations and a membrane cofactor protein (gene symbol, CD46) gene polymorphism. Five years posttransplantation, an allograft biopsy specimen showed numerous mesangial and extramembranous C3 deposits, although the patient had no biological sign of glomerulopathy. Nine years after transplantation, he was well with stable kidney function. Patient 2, who had a homozygous CFH mutation, developed glomerulonephritis with isolated C3 deposits 5 months after kidney transplantation while he was treated for early recurrenceof hemolytic anemia. Four years later, the second kidney transplant biopsy specimen showed recurrence of thrombotic microangiopathy. Six years posttransplantation, kidney function was stable and complete blood cell count was normal with regular plasma therapy. These observations suggest that constitutional dysregulation of the alternative pathway is associated with a wide spectrum of kidney diseases, and glomerulonephritis with isolated C3 deposits and thrombotic microangiopathy may be different expressions of the same condition. Several factors could influence the disease, such as degree of CFH haploinsufficiency and other complement alternative pathway regulator abnormalities, such as a membrane cofactor protein polymorphism.
机译:我们报告第一例非典型溶血和尿毒症综合征,在肾脏移植后与天然肝和肾小球性肾炎中的补体因子H(CFH)缺乏相关,伴有孤立的C3沉积物。两个男孩在16和11个月大时出现了非典型溶血和尿毒症综合征,伴有低C3和CFH水平。两者均迅速发展至终末期肾衰竭,并接受了肾脏移植。患者1合并CFH和补体因子I(CFI)杂合突变和膜辅因子蛋白(基因符号,CD46)基因多态性。移植后五年,尽管患者没有肾小球病的生物学体征,但同种异体移植活检标本显示大量的系膜和膜外C3沉积物。移植九年后,他的肾脏功能稳定。患者2,具有纯合CFH突变,在肾移植后5个月因溶血性贫血的早期复发而接受治疗,患肾小球肾炎并伴有C3沉积。四年后,第二次肾脏移植活检标本显示血栓性微血管病复发。移植后六年,常规血浆疗法可使肾功能稳定且全血细胞计数正常。这些观察结果表明,替代途径的体质失调与广泛的肾脏疾病有关,并且具有孤立的C3沉积物和血栓性微血管病的肾小球肾炎可能是同一疾病的不同表达。多种因素可能会影响该疾病,例如CFH单倍剂量不足的程度和其他补体替代途径调节因子异常,例如膜辅因子蛋白多态性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号